Josep Maria Grinyó Selected Research

Albuminuria

6/2021

The gene silencing of IRF5 and BLYSS effectively modulates the outcome of experimental lupus nephritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Josep Maria Grinyó Research Topics

Disease

2	Proteinuria 06/2021 - 01/2015
2	Inflammation (Inflammations) 01/2017 - 05/2004
1	Disease Progression 06/2021
1	Albuminuria 06/2021
1	Lupus Nephritis 06/2021
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2017
1	Fibrosis (Cirrhosis) 01/2017
1	Neoplasms (Cancer) 01/2017
1	Ureteral Obstruction 01/2017
1	Anemia 01/2015
1	Kidney Diseases (Kidney Disease) 01/2015
1	Delayed Graft Function 01/2009
1	Renal Insufficiency (Renal Failure) 08/2004

Drug/Important Bio-Agent (IBA)

1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2021
1	AntibodiesIBA 06/2021
1	Antigen-Antibody Complex (Immune Complex)IBA 06/2021
1	MTOR InhibitorsIBA 01/2017
1	TOR Serine-Threonine KinasesIBA 01/2017
1	AntigensIBA 01/2017
1	EnzymesIBA 01/2017
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2017
1	Calcineurin InhibitorsIBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2015
1	Basiliximab FDA Link 01/2009
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2009
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 08/2004
1	Protein Kinases (Protein Kinase)IBA 05/2004

Therapy/Procedure

2	Therapeutics 06/2021 - 01/2009
2	Kidney Transplantation 01/2017 - 01/2015
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2017
1	Transplantation 01/2015